Workshop on the General Data Protection Regulation (GDPR) and secondary use of data for medicines and public health purposes
Date:
29/09/2020
Location:
Virtual meeting
This half-day virtual workshop with medicines developers and EMA’s network of research-performing, research-supporting academic infrastructures and data providers, participants will be given an overview of European Commission’s (EC) work on the creation of the European Health Data Space, followed by a discussion on the development of an EU-wide governance framework and a future code of conduct on the processing of personal data in the health sector. Additionally, the application of GDPR in the health sector and the secondary use of health data for medicines and public health purposes will be addressed at the meeting.
-
List item
Agenda - Workshop on the General Data Protection Regulation (GDPR) and secondary use of data for medicines and public health purposes (PDF/167.11 KB)
Draft
First published: 14/07/2020
Last updated: 29/09/2020
EMA/350890/2020 -
List item
Presentation - Towards European health data space (Martin Dorazil) (PDF/898.24 KB)
First published: 05/03/2021 -
List item
Presentation - Role of the European Health Data Space (EHDS) in the German presidency (A. Brandes) (PDF/615.21 KB)
First published: 05/03/2021 -
List item
Presentation - Towards European Health Data Space Joint Action (TEHDAS) for the European Health Data Space (Markus Kalliola) (PDF/390.21 KB)
First published: 05/03/2021 -
List item
Presentation - Brief Introduction to EMA’s survey (Sabine Brosch) (PDF/556.69 KB)
First published: 05/03/2021 -
List item
Presentation - General Data Protection Regulation (GDPR): ESMO’S concerns (Paolo Casali) (PDF/1.39 MB)
First published: 05/03/2021 -
List item
Presentation - Academia feedback General Data Protection Regulation (GDPR) and secondary data use (PDF/2.29 MB)
First published: 05/03/2021 -
List item
Presentation - Questions and answers on data protection and the secondary use of personal data for medicines development and public health purposes (PDF/531.41 KB)
First published: 05/03/2021 -
List item
Presentation - Secondary use of personal data for medicines development (Martijn Ten Bloemendal) (PDF/484.74 KB)
First published: 05/03/2021